Clinical Trial Update: Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial evaluating weekly docetaxel and cisplatin with capecitabine and bevacizumab in advanced gastric cancer. The trial status is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Rabin Medical Center | Conditions: Advanced Gastric Cancer | Phase 1, Phase 2 | Status: UNKNOWN